spacer
home > pmps > winter 2017 > left to your own devices
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Left to Your Own Devices

It is one of the great conundrums of treating chronic disease: while huge advances have been made in developing innovative therapies, these often go unrealised due to poor adherence by patients not taking their prescribed medicines, continuing to hamper quality healthcare outcomes.

There is a lengthy list of explanations, be they personal, technical or economic, but it is thought that between 33 and 50% of all treatments prescribed for long-term conditions are not taken as recommended. The problem is all too apparent in respiratory disease where, despite significant advances in inhalers for the treatment of asthma and chronic obstructive pulmonary disease (COPD), many patients continue to experience poor disease control.

Studies have shown adherence rates in asthma and COPD vary from 22% up to a frightening 78%. Given that preventer (used daily for control) and reliever (rescue) inhalers are the mainstay of treatment, compliance is vital to enhance quality of life, control symptoms and prevent asthma attacks and COPD exacerbations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dana Shears has over 25 years’ experience within the drug delivery industry. He has spent the past 11 years with H&T Presspart, part of the Heitkamp and Thumann Group, and is currently the Sales and Business Development Director for the Americas region. Dana is also responsible for commercial activities relating to the electronic MDI platform technology. He received his Bachelor’s Degree in Engineering from West Virginia University, US.

Melissa Manice has a PhD in Clinical and Translational Research from the Icahn School of Medicine at Mount Sinai, US, specialising in Pulmonary Medicine and Biostatistics. Cohero Health is a result of her career in academic clinical medicine, as she saw a deep need to build the solution rather than spend a lifetime studying the problem. Melissa’s years of clinical research and managerial experience have developed important relationships at leading academic medical centres, overseeing the design and execution of large multi-site trials.
spacer
Dana Shears
spacer
spacer
spacer
Melissa Manice
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cambridge Sensotec (manufacturers of Dynascan) obtains new ISO accreditation

On the 30th May 2019, Cambridge Sensotec proudly achieved ISO 9001:2015 accreditation under the BSI (British Standards Institution). Cambridge Sensotec Ltd now joins 1.3 million companies across 112 countries worldwide that hold this prestigious certificate.
More info >>

White Papers
 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement